40 selected records with a cited source date in 2008. This archive is selective and does not imply continuous monitoring or complete historical coverage.
The official Drugs@FDA dataset lists original submission 1 for NDA 022201 with status AP dated 2008-12-24, and names degarelix acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 076396 with status AP dated 2008-11-17, and names calcitonin salmon among the application record's active ingredients.
The Federal Register published notice E8-27179, attributed to FDA and its parent HHS department, on 2008-11-17. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.
The Federal Register published notice E8-24356, attributed to FDA and its parent HHS department, on 2008-10-15. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.
The Federal Register published rule E8-24050, attributed to FDA and its parent HHS department, on 2008-10-09. Its official title is “Distribution of Certain Drug Products by Registered Blood Establishments and Comprehensive Hemophilia Diagnostic Treatment Centers That Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.
PeptideScanner retained PubMed bibliographic metadata for PMID 11188738 at 2026-07-30T22:38:13.871Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 2001-02-24. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 8193332 at 2026-07-30T22:38:13.861Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1994-01-01. PeptideScanner associated this retained record with the identity slug emideltide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 8679991 at 2026-07-30T22:38:13.862Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1996-01-01. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 8998343 at 2026-07-30T22:38:13.864Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1996-11-01. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 9303728 at 2026-07-30T22:38:13.866Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1997-07-01. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 9606550 at 2026-07-30T22:38:13.868Z. PubMed recorded a metadata revision date of 2008-10-08 and an Entrez history date of 1998-06-02. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
PubMed lists PMID 18833867 in Connecticut medicine as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2008-10 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PeptideScanner retained ClinicalTrials.gov record NCT00369694 at 2026-11-15T21:47:40.408Z. Its registry update date was 2008-09-25, and PeptideScanner's reviewed identity mapping was terlipressin.
PeptideScanner retained PubMed bibliographic metadata for PMID 18756821 at 2026-07-30T22:38:13.932Z. PubMed recorded a metadata revision date of 2008-09-01 and an Entrez history date of 2008-09-02. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained ClinicalTrials.gov record NCT00001036 at 2026-11-15T22:10:40.222Z. Its registry update date was 2008-07-30, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.
PeptideScanner retained PubMed bibliographic metadata for PMID 18630353 at 2026-07-30T22:38:13.928Z. PubMed recorded a metadata revision date of 2008-07-15 and an Entrez history date of 2008-07-17. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 18623910 at 2026-07-30T22:38:13.927Z. PubMed recorded a metadata revision date of 2008-07-14 and an Entrez history date of 2008-07-16. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained ClinicalTrials.gov record NCT00461422 at 2026-11-15T22:03:26.540Z. Its registry update date was 2008-06-27, and PeptideScanner's reviewed identity mapping was ganirelix.
PeptideScanner retained PubMed bibliographic metadata for PMID 18477986 at 2026-07-30T22:38:13.910Z. PubMed recorded a metadata revision date of 2008-06-23 and an Entrez history date of 2008-05-15. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.
PubMed lists PMID 17044786 in Hybridoma (2005) as Journal Article, with publication-date metadata of 2006-10 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PeptideScanner retained PubMed bibliographic metadata for PMID 18488900 at 2026-07-30T22:38:13.911Z. PubMed recorded a metadata revision date of 2008-05-20 and an Entrez history date of 2008-05-21. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
The official Drugs@FDA dataset lists original submission 1 for NDA 021795 with status AP dated 2008-05-08, and names desmopressin acetate among the application record's active ingredients.
PeptideScanner retained ClinicalTrials.gov record NCT00670501 at 2026-07-30T22:36:49.601Z. Its registry update date was 2008-05-01, and PeptideScanner's reviewed identity mapping was teriparatide.
PeptideScanner retained PubMed bibliographic metadata for PMID 18334980 at 2026-07-30T22:38:13.898Z. PubMed recorded a metadata revision date of 2008-04-28 and an Entrez history date of 2008-03-13. PeptideScanner associated this retained record with the identity slug teriparatide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained PubMed bibliographic metadata for PMID 18431004 at 2026-07-30T22:38:13.909Z. PubMed recorded a metadata revision date of 2008-04-23 and an Entrez history date of 2008-04-24. PeptideScanner associated this retained record with the identity slug semax. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained ClinicalTrials.gov record NCT00657761 at 2026-11-16T01:41:15.051Z. Its registry update date was 2008-04-14, and PeptideScanner's reviewed identity mapping was enfuvirtide.
PeptideScanner retained ClinicalTrials.gov record NCT00370253 at 2026-11-15T21:47:40.408Z. Its registry update date was 2008-04-11, and PeptideScanner's reviewed identity mapping was terlipressin.
PubMed lists PMID 18396778 in In vivo (Athens, Greece) as Journal Article, with publication-date metadata of 2008 Jan-Feb (source-text precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PeptideScanner retained ClinicalTrials.gov record NCT00244452 at 2026-11-15T22:02:39.332Z. Its registry update date was 2008-03-31, and PeptideScanner's reviewed identity mapping was cetrorelix.
PeptideScanner retained PubMed bibliographic metadata for PMID 18283327 at 2026-07-30T22:38:13.895Z. PubMed recorded a metadata revision date of 2008-03-21 and an Entrez history date of 2008-02-20. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.
PeptideScanner retained ClinicalTrials.gov record NCT00428415 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-05, and PeptideScanner's reviewed identity mapping was tesofensine.
PeptideScanner retained ClinicalTrials.gov record NCT00006077 at 2026-11-16T17:29:46.323Z. Its registry update date was 2008-03-04, and PeptideScanner's reviewed identity mapping was tesofensine.
PeptideScanner retained ClinicalTrials.gov record NCT00628121 at 2026-11-15T22:02:39.332Z. Its registry update date was 2008-03-04, and PeptideScanner's reviewed identity mapping was cetrorelix.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077329 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077330 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077331 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.
PeptideScanner retained ClinicalTrials.gov record NCT00034047 at 2026-11-16T01:35:57.709Z. Its registry update date was 2008-01-25, and PeptideScanner's reviewed identity mapping was nafarelin.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077453 with status AP dated 2008-01-24, and names oxytocin among the application record's active ingredients.
PubMed lists PMID 17971793 in Nature clinical practice. Endocrinology & metabolism as Journal Article, with publication-date metadata of 2007-10-30 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-2. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PeptideScanner retained ClinicalTrials.gov record NCT00489645 at 2026-07-30T22:36:49.602Z. Its registry update date was 2008-01-16, and PeptideScanner's reviewed identity mapping was pramlintide.